GlaxoSmithKline (NYSE: GSK) reported Q3 EPS of 22.6 pence, versus 27.2 pence reported last year. Revenue for the quarter came in at GBP6.53 billion, versus GBP7.1 billion reported last year.

For earnings history and earnings-related data on GlaxoSmithKline (GSK) click here.

Earnings Hot Earnings